The eighth edition of the Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures and trends. Based on primary data from HDA specialty distributor members and research from healthcare organizations, Specialty Pharmaceutical Distribution: Facts, Figures and Trends explores the characteristics of the specialty segment, including distributor performance metrics (finance/operations/services); distribution models (and the factors that influence the use of open, limited and exclusive models); as well as summaries of key segment drivers like drugs under-development and policies that will impact future trends. This edition also includes a sections on the rise of biosimilars and a spotlight on Oncology.
Download your electronic version
Read the press release
For more information, contact Madeline Nardacci at (703) 885-0235.
CuraScript Specialty Distribution
Genentech, a Member of the Roche Group
H. D. Smith Foundation
Takeda Pharmaceuticals America, Inc.